- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Events
Page 349
Baidu catches Kitt.AI
Baidu has paid an undisclosed amount to acquire Kitt.Ai, an Amazon Alexa Fund-backed AI language technology developer.
Jul 7, 2017Sienna to scratch IPO itch
Topical skin treatment developer and JLabs graduate Sienna Biopharmaceuticals has filed for a $74.8m initial public offering, after raising $86m in venture funding.
Jul 7, 2017Jawbone locks up as liquidation process begins
The Deutsche Telekom-backed wearable fitness tracker developer was once valued at more than $3bn, but has now begun liquidation proceedings.
Jul 7, 2017MyRepublic begins journey to IPO
Sinar Mas and Dian Swastatika Sentosa-backed internet service provider MyRepublic is targeting the end of 2018 for an initial public offering, its CEO has said.
Jul 6, 2017Unchained Labs links to Novo in $13m round
Existing investor Novo Ventures contributed to a series C round announced alongside Unchained Labs' acquisition of protein measurement device maker Trinean.
Jul 5, 2017Roche eats up MySugr
The pharmaceutical company has bought diabetes management platform MySugr for an undisclosed sum, two years after its corporate venturing unit backed a $4.8m seed round.
Jul 5, 2017InfoScout gets on Market Track in acquisition deal
Dunnhumby Ventures has exited consumer analytics provider InfoScout in a cash and stock purchase by business intelligence company Market Track.
Jul 5, 2017Snapdeal turns down nine-figure Flipkart offer
The corporate-backed online marketplace is reportedly holding out for $1bn, having rejected an acquisition offer of between $550m and $900m.
Jul 5, 2017Kinvey gives way to Progress in $49m acquisition
Progress Software has acquired business app development platform Kinvey, which had raised almost $18m from backers including NTT Docomo Ventures and Verizon Ventures.
Jul 4, 2017Clementia to form $115m IPO
The bone disease therapy developer had raised $92.5m from investors including UCB Pharma across two rounds in 2015.
Jul 4, 2017About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


